Apellis Pharmaceuticals
APLS
APLS
174 hedge funds and large institutions have $2.8B invested in Apellis Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 62 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 62
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
23% less capital invested
Capital invested by funds: $3.65B → $2.8B (-$856M)
Holders
174
Holding in Top 10
5
Calls
$24.1M
Puts
$7.55M
Top Buyers
| 1 | +$42.9M | |
| 2 | +$33.4M | |
| 3 | +$25.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.7M |
Top Sellers
| 1 | -$59.4M | |
| 2 | -$44.3M | |
| 3 | -$20.2M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$17.2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$9.96M |